EUS for detection of the hepatocellular carcinoma: results of a prospective study

Gastrointestinal Endoscopy

Volumn 66, Issue 2, 2007, Pages 265-273

  Singh, Pankaj ^a   Erickson, Richard A ^a   Mukhopadhyay, Phalguni ^a   Gopal, Shanthi ^a   Kiss, Alex ^a   Khan, Ahmed ^a   Ulf Westblom, T ^a  

^a Division of Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; ASPIRATION BIOPSY; CANCER DIAGNOSIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; HEPATITIS B; HEPATITIS C; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; CARCINOMA, HEPATOCELLULAR; ENDOSONOGRAPHY; HUMANS; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 34447536517     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2006.10.053     Document Type: Article

References (35)

1. El-Serag H.B., and Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340 (1999) 745-750
2. Pawarode A., Voravud N., Sriruranpong K., et al. Natural history of untreated primary hepatocellular carcinoma: a retrospective study of 157 patients. Am J Clin Oncol 21 (1998) 386-391
3. Trevisani F., D'Intino P.E., Grazi G.L., et al. Clinical and pathologic features of hepatocellular carcinoma in young and older Italian patients. Cancer 77 (1996) 2223-2232
4. Mazzafero V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (1996) 693-699
5. Bruix J., Sherman M., Llovet J.M., et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol 35 (2001) 421-430
6. Gambarin-Gelwan M., Wolf D.C., Shapiro R., et al. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation. Am J Gastroenterol 95 (2000) 1535-1538
7. Nguyen M.H., Garcia R.T., Simpson P.W., et al. Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis. Hepatology 36 (2002) 410-417
8. Dodd III G.D., Miller W.J., Baron R.L., et al. Detection of malignant tumors in end-stage cirrhotic livers: efficacy of sonography as a screening technique. AJR Am J Roentgenol 159 (1992) 727-733
9. Trevisani F., D'Intino P.E., Morselli-Labate A.M., et al. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol 34 (2001) 570-575
10. Miller W.J., Baron R.J., Dodd III G.D., et al. Malignancies in patients with cirrhosis: CT sensitivity and specificity in 200 consecutive transplant patients. Radiology 193 (1994) 645-650
11. Peterson M.S., Baron R.L., Marsh Jr. J.W., et al. Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation. Radiology 217 (2000) 743-749
12. Schwartz M. Liver transplantation for hepatocellular carcinoma. Gastroenterology 127 Suppl 1 (2004) S268-S276
13. Burrel M., Llovet J.M., Ayuso C., et al. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology 38 (2003) 1034-1042
14. Stark D.D., Wittenberg J., Butch R.J., et al. Hepatic metastases: randomized, controlled comparison of detection with MR imaging and CT. Radiology 165 (1987) 399-406
15. Mazaferro V., Regalia E., Docci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (1996) 693-699
16. Wiesner R.H., Freeman R.B., and Mulligan D.C. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology 127 Suppl 1 (2004) S261-S267
17. Nguyen P., Feng J.C., and Chang K.J. Endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration (FNA) of liver lesions. Gastrointest Endosc 50 (1999) 357-361
18. Prasad P., Schmulewitz N., Patel A., et al. Detection of occult liver metastases during EUS for staging of malignancies. Gastrointest Endosc 59 (2004) 49-53
19. DeWitt J., LeBlanc J., McHenry L., et al. Endoscopic ultrasound-guided fine needle aspiration cytology of solid liver lesions: a large single-center experience. Am J Gastroenterol 98 (2003) 1976-1981
20. Hollerbach S., Willert J., Topalidis T., et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy of liver lesions: histological and cytological assessment. Endoscopy 35 (2003) 743-749
21. Awad S.S., Fargan S., Abudayyeh S., et al. Preoperative evaluation of hepatic lesions for the staging of hepatocellular and metastatic liver carcinoma using endoscopic ultrasonography. Am J Surg 184 (2002) 601-604
22. Bogstad J., Vilmann P., and Burcharth F. Early detection of recurrent hepatocellular carcinoma by endosonographically guided fine-needle aspiration biopsy. Endoscopy 29 (1997) 322-324
23. Talwalkar J.A., and Gores G.J. Diagnosis and staging of hepatocellular carcinoma. Gastroenterology 127 Suppl 1 (2004) S126-S132
24. Durand F., Regimbeau J.M., Belghiti J., et al. Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J Hepatol 35 (2001) 254-258
25. Krinsky G.A., and Israel G. Nondysplastic nodules that are hyperintense on T1-weighted gradient-echo MR imaging: frequency in cirrhotic patients undergoing transplantation. AJR Am J Roentgenol 180 (2003) 1023-1027
26. Anthony P.P., Vogel C.L., and Barker L.F. Liver cell dysplasia: a premalignant condition. J Clin Pathol 26 (1973) 217-223
27. Ho J.C.I., Wu P.C., and Mark T.K. Liver cell dysplasia in association with hepatocellular carcinoma, cirrhosis and hepatitis B surface antigen in Hong Kong. Int J Cancer 28 (1981) 571-574
28. Watanabe S., Okita K., Harada T., et al. Morphologic studies of the liver cell dysplasia. Cancer 51 (1983) 2197-2205
29. Akagi G., Furuya K., Kanamura A., et al. Liver cell dysplasia and hepatitis B surface antigen in liver cirrhosis and hepatocellular carcinoma. Cancer 54 (1984) 315-318
30. Ganne-Carrie N., Chastang C., Chapel F., et al. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cel dysplasia in western patients with cirrhosis. Hepatology 23 (1996) 1112-1118
31. Nakanuma Y., Kanel G.C., Doishita K., et al. Risk lesions in cirrhosis and development of hepatocellular carcinoma: an autopsy study. Biomed Pharmacother 43 (1989) 127-133
32. Roncalli M., Kobayashi M., Ikeda K., et al. Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis. Cancer 106 (2006) 636-647
33. Podda M., Roncalli M., Battezzati P.M., et al. Liver cell dysplasia and hepatocellular carcinoma. Ital J Gastroenterol 24 (1992) 39-42
34. Borzio M., Bruno S., Roncalli M., et al. Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study. Gastroenterology 108 (1995) 812-817
35. ten Berge J., Hoffman B.J., Hawes R.H., et al. EUS-guided fine needle aspiration of the liver: indications, yield, and safety based on an international survey of 167 cases. Gastrointest Endosc 55 (2002) 859-862